Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 4/2012

01-04-2012 | Short Communication

An extensive hemimelic polyostotic fibrous dysplasia: a case report

Authors: D. Mrabet, S. Rekik, H. Sahli, M. Ben Amor, N. Meddeb, S. Sellami

Published in: Rheumatology International | Issue 4/2012

Login to get access

Abstract

We report a new case of polyostotic fibrous dysplasia (FD). A 26-year-old woman was referred to our department complaining of pain in her left arm. She had suffered for tow fractures in left leg and arm previously. Plain radiographs showed osteolytics lesions at the left humerus and radius. Histological examination of the surgical specimens showed FD. She has beneficed with zoledronic acid perfusion.
Literature
1.
Chapurlat RD, Orcel P (2008) Fibrous dysplasia of bone and McCune-Albright syndrome. Best Pract Res Clin Rheumatol 22:55–69PubMedCrossRef
2.
Kashima TG, Nishiyama T, Kazuhiro S, Shimazaki M, Isao K, Grigoriadis AE et al (2009) Periotin, a novel marker of intramenbranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions. Hum Pathol 40:226–237PubMedCrossRef
3.
Feller L, Wood NH, Khammissa RA, Lemmer J, Raubenheimer EJ (2009) The nature of fibrous dysplasia. Head Face Med 5:22–27PubMedCrossRef
4.
DiCaprio MR, Enneking W (2005) Fibrous dysplasia. Pathophysiology, evaluation and treatement. J Bone Joint Surg 87:1848–1864PubMedCrossRef
5.
Mansoori LS, Catel CP, Rothman MS (2010) Bisphosphonate treatment in polyostotic fibrous dysplasia of the cranium: case report and literature review. Endocr Pract 16:1–14CrossRef
6.
Nambi GI, Jacob J, Gupta AK (2010) Monofocal maxillary fibrous dysplasia with orbital, nasal and oral obstruction. J Plast Reconstr Aesthet Surg 63:16–18CrossRef
7.
Godse AS, Shrotriya SP, Vaid NS (2009) Fibrous dysplasia of the maxilla. J Pediatr Surg 44:849–851PubMedCrossRef
8.
Leet AI, Magur E, Lee JS, Wientroub S, Robey PG, Collins MT (2004) Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis. J Bone Joint Surg Am 86:531–537PubMed
9.
Takechi R, Shinozaki T, Fukuda T, Yanagawa T, Takagishi K (2009) Involvement of the proximal tibial epiphysis by monostotic fibrous dysplasia. Clin Imaging 33:154–157PubMedCrossRef
10.
Baldwin NG (1999) Surgical treatment of cervical spine fibrous dysplasia: technical case report and review. Neurosurgery 44:1346–1347
11.
Chapulat RD (2006) Medical therapy in adults with fibrous dysplasia of bone. J Bone Miner Res 21:114–119CrossRef
12.
Chao K, Katznelson L (2008) Use of high-dose oral bisphosphonate therapy for symptomatic fibrous dysplasia of the skull. J Neurosurg 109:889–892PubMedCrossRef
13.
Muriel S, Oliveri B (2009) Long-term pamidronate treatement of polyostotic fibrous dysplasia of bone: a case series in young adults. Curr Ther Res Clin Exp 70:161–172CrossRef
14.
Isaia GC, Lala R, Defilippi C et al (2002) Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone firous dysplasia. Calcif Tissue Int 71:121–128PubMedCrossRef
15.
Lane JM, Khan SN, O’Connor WJ et al (2001) Bisphosphonate therapy in fibrous dysplasia. Clin Orthop Relat Res 382:6–12PubMedCrossRef
Metadata
Title
An extensive hemimelic polyostotic fibrous dysplasia: a case report
Authors
D. Mrabet
S. Rekik
H. Sahli
M. Ben Amor
N. Meddeb
S. Sellami
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1833-y

Other articles of this Issue 4/2012

Rheumatology International 4/2012 Go to the issue

Original Article

Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India

Case Report

Development of sarcoidosis following etanercept treatment: a report of three cases

Review

T helper cell subsets in arthritis and the benefits of immunomodulation by 1,25(OH)2 vitamin D

Letter to the Editors

RETRACTED ARTICLE: Systemic sclerosis and malignancies after cyclophosphamide therapy: a single center experience

Original Article

Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis

Original Article

Prospective evaluation of free radicals and antioxidant activity following 6-month risedronate treatment in patients with postmenopausal osteoporosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits